Name | [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate |
---|---|
Synonyms |
[2S-[2a(R*),3b]]-N-Formyl-L-leucine 1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester
(−)-Tetrahydrolipstatin N-Formyl-L-leucine ester with (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone (2S)-1-[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl]-2-tridecanyl N-formyl-L-leucinate Tetrahydrolipstatin MFCD05662360 (2S)-1-[(2S,3S)-3-Hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate Alli (1S)-1-{[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]methyl}dodecyl N-formyl-L-leucinate Orlistat (1S)-1-{[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]methyl}dodecyl (2S)-2-(formylamino)-4-methylpentanoate Orlipastat Orlipastatum L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester Xenical (-)-Tetrahydrolipstatin THLP |
Description | Orlistat is a lipase inhibitor for obesity management that acts by inhibiting the absorption of dietary fats. |
---|---|
Related Catalog | |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 615.9±30.0 °C at 760 mmHg |
Melting Point | <50ºC |
Molecular Formula | C29H53NO5 |
Molecular Weight | 495.735 |
Flash Point | 326.3±24.6 °C |
Exact Mass | 495.392365 |
PSA | 81.70000 |
LogP | 8.94 |
Appearance | solid | white |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.470 |
Storage condition | 2-8°C |
Water Solubility | DMSO: 19 mg/mL |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | OH3167600 |
Precursor 0 | |
---|---|
DownStream 7 | |